PREVENTIONMINIMIZATION OF ADENOVIRUS INFECTION

Document Sample
PREVENTIONMINIMIZATION OF ADENOVIRUS INFECTION Powered By Docstoc
					PREVENTION/MINIMIZATION OF
   ADENOVIRUS INFECTION

                  18 September 2001

          COL Benedict M. Diniega, MD, MPH
   Program Director, Preventive Medicine & Surveillance
      DoD (Health Affairs/Health Operations Policy)
           BACKGROUND
• AFEB - several recommendations
  concerning use of ADV vaccine in the
  military
• Used by Army, Navy, and Marines in
  recruit training camps
• Production of adenovirus vaccines (Type 4
  and Type 7) ended in 1996
            BACKGROUND
• Supplies extended
• Type 4 ran out in 1998;
  Type 7 in 1999
• Since 1999, 10-12% of recruits ill with
  adenovirus infection
  – Several outbreaks
  – 2 deaths in recruits in 2000
   PROCUREMENT EFFORTS

• 2000 - MRMC (USAMMA) sought new
  manufacturer
• 2001 - Several responses to RFP
• Contract award will be made shortly
• Once award made, will take years (5-6
  years) for approval and production
      QUESTION TO AFEB

• Review known and suggested non-
  vaccine methods to minimize/control
  transmission
• Recommend potentially effective non-
  vaccine methods of transmission
  control